What happened
Shares of biotechnology outfit AbCellera Biologics(NASDAQ:ABCL) were up 17.2% as of mid-session Friday following encouraging commentary within its second-quarter report.
So what
It certainly could have been worse.
For the three-month span…
Why AbCellera Biologics Stock Was Up More Than 17% on Friday – Motley Fool
Share this article
More News
Investors Withdrew Cash From Crypto ETFs, Except for One Altcoin
November 5, 2026
Ministry issues new rules for crypto-asset market
November 5, 2026
How to Convert Crypto to Cash Using an Off-Ramp
November 5, 2026
SEC staying on pro-crypto path? Division backs Canton Coin.
November 4, 2026